Allovir Valuation
| ALVRDelisted Stock | USD 9.81 0.26 2.72% |
At this time, the firm appears to be overvalued. Allovir shows a prevailing Real Value of $8.36 per share. The current price of the firm is $9.81. Our model approximates the value of Allovir from analyzing the firm fundamentals such as Shares Owned By Insiders of 49.11 %, current valuation of (69.57 M), and Return On Equity of -0.8 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Allovir's price fluctuation is very steady at this time. Calculation of the real value of Allovir is based on 3 months time horizon. Increasing Allovir's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Allovir stock is determined by what a typical buyer is willing to pay for full or partial control of Allovir. Since Allovir is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Allovir Stock. However, Allovir's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.81 | Real 8.36 | Hype 9.81 | Naive 10.14 |
The intrinsic value of Allovir's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Allovir's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Allovir helps investors to forecast how Allovir stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allovir more accurately as focusing exclusively on Allovir's fundamentals will not take into account other important factors: About Allovir Valuation
The delisted stock valuation mechanism determines Allovir's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Allovir based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Allovir. We calculate exposure to Allovir's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Allovir's related companies.Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Allovir Stock
If you are still planning to invest in Allovir check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allovir's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |